ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 45 filers reported holding ACORDA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $858,000 | -62.4% | 1,000,000 | -66.7% | 1.49% | -47.5% |
| Q4 2016 | $2,280,000 | -34.8% | 3,000,000 | -25.0% | 2.84% | -9.8% |
| Q2 2016 | $3,495,000 | -1.5% | 4,000,000 | 0.0% | 3.15% | -12.6% |
| Q1 2016 | $3,548,000 | -22.9% | 4,000,000 | -20.0% | 3.61% | -7.7% |
| Q4 2015 | $4,600,000 | -7.3% | 5,000,000 | -9.1% | 3.90% | +3.3% |
| Q3 2015 | $4,964,000 | +9.0% | 5,500,000 | 0.0% | 3.78% | +33.7% |
| Q2 2015 | $4,556,000 | -1.1% | 5,500,000 | +22.2% | 2.83% | +24.1% |
| Q1 2015 | $4,607,000 | +14.4% | 4,500,000 | +28.6% | 2.28% | +15.2% |
| Q4 2014 | $4,027,000 | +29.4% | 3,500,000 | +16.7% | 1.98% | +30.3% |
| Q3 2014 | $3,113,000 | – | 3,000,000 | – | 1.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 7,500 | $6,276,000 | 2.99% |
| PFM Health Sciences, LP | 90,886,000 | $75,652,000 | 2.01% |
| Jabre Capital Partners S.A. | 1,750,000 | $1,474,000 | 1.68% |
| Partner Investment Management, L.P. | 1,108,000 | $922,000 | 1.15% |
| Telemetry Investments, L.L.C. | 2,000,000 | $1,655,000 | 1.06% |
| Worth Venture Partners, LLC | 1,562,000 | $1,312,000 | 0.99% |
| DLD Asset Management, LP | 12,000,000 | $10,028,000 | 0.69% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,937,000 | 0.67% |
| CANYON CAPITAL ADVISORS LLC | 28,775,000 | $23,830,000 | 0.56% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $1,665,000 | 0.49% |